Literature DB >> 12410707

Taking treatment to the patient: development of a home TL-01 ultraviolet B phototherapy service.

H Cameron1, S Yule, H Moseley, R S Dawe, J Ferguson.   

Abstract

BACKGROUND: While most patients requiring phototherapy can attend for hospital-based out-patient ultraviolet (UV) B therapy, a significant number cannot attend because of geographical, work, economic and other reasons.
OBJECTIVES: To determine whether there was a need for home phototherapy in the Tayside area and, if so, to establish protocols and then to assess if such a service would be workable.
METHODS: Patients referred from dermatology out-patient clinics in Tayside for narrow-band UVB (TL-01) phototherapy completed a pilot questionnaire that was followed by a two-phase project. In phase 1, patients with psoriasis were trained to use the home phototherapy equipment (HoPE) within the hospital department under nursing supervision while a teaching package and protocols were developed. In phase 2, home phototherapy was made available for patient use in the community, supported by a specialist home phototherapy nurse. Waldmann UV100 home therapy units were used, with accurate dosimetry. Detailed treatment records were kept and questionnaires were used to assess acceptability and costs of therapy.
RESULTS: Fifty-two pilot questionnaires were completed. Forty-two per cent of respondents found hospital phototherapy inconvenient and 75% felt phototherapy at home would be helpful. In phase 1, seven of 10 patients trained to use the HoPE completed therapy with the HoPE unit alone, reaching minimal residual activity (MRA) or clearance in a median of 18 exposures (median dose 10.38 J cm-2). In phase 2, 32 courses of home phototherapy were given to 30 patients. Of 23 with psoriasis, 18 reached clearance or MRA in a median of 22.5 exposures (median dose 9.84 J cm-2). Although self-reported erythema rates appeared higher than expected, all post-treatment questionnaire respondents would choose home phototherapy over hospital therapy if required in the future.
CONCLUSIONS: UVB (TL-01) home phototherapy is a useful practical development that has fulfilled a need in our catchment area. Where appropriate training and support teams are available it appears to be similar in effectiveness to hospital therapy, to be safe and to be cost-effective for patients.

Entities:  

Mesh:

Year:  2002        PMID: 12410707     DOI: 10.1046/j.1365-2133.2002.04860.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  9 in total

1.  National Psoriasis Foundation Priorities for Patient-Centered Research: Proceedings from the 2016 Conference.

Authors:  Ladan Afifi; Lindsey Shankle; April W Armstrong; Marc Boas; Alisha Bridges; Vivian Chiguil; Frank Doris; Kristina Callis Duffin; Eric Fielding; Roy Fleischmann; Joel M Gelfand; Matthew Kiselica; Catherine Kiselica; Brian LaFoy; John J Latella; Junko Takeshita; Sarah Truman; Marilyn T Wan; Vickie Wilkerson; Jashin J Wu; Michael P Siegel; Wilson Liao
Journal:  J Psoriasis Psoriatic Arthritis       Date:  2017

2.  Home Narrowband Ultraviolet B Phototherapy for Photoresponsive Skin Conditions: A Health Technology Assessment.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2020-11-02

3.  Cost effectiveness of home ultraviolet B phototherapy for psoriasis: economic evaluation of a randomised controlled trial (PLUTO study).

Authors:  Mayke B G Koek; Vigfús Sigurdsson; Huib van Weelden; Paul H A Steegmans; Carla A F M Bruijnzeel-Koomen; Erik Buskens
Journal:  BMJ       Date:  2010-04-20

4.  Ultraviolet Phototherapy Management of Moderate-to-Severe Plaque Psoriasis: An Evidence-Based Analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2009-11-01

5.  UVB phototherapy in an outpatient setting or at home: a pragmatic randomised single-blind trial designed to settle the discussion. The PLUTO study.

Authors:  Mayke B G Koek; Erik Buskens; Paul H A Steegmans; Huib van Weelden; Carla A F M Bruijnzeel-Koomen; Vigfús Sigurdsson
Journal:  BMC Med Res Methodol       Date:  2006-08-01       Impact factor: 4.615

6.  Prescribing and using vitiligo treatments: lessons from a nested process evaluation within the HI-Light vitiligo randomized controlled trial.

Authors:  Paul Leighton; Joanne R Chalmers; Jonathan M Batchelor; Andy Rogers; Perways Akram; Rachel H Haines; Garry D Meakin; Jennifer White; Jane C Ravenscroft; Tracey H Sach; Miriam Santer; Maxine E Whitton; Viktoria Eleftheriadou; Kim S Thomas
Journal:  Clin Exp Dermatol       Date:  2022-05-30       Impact factor: 4.481

7.  Home versus outpatient ultraviolet B phototherapy for mild to severe psoriasis: pragmatic multicentre randomised controlled non-inferiority trial (PLUTO study).

Authors:  Mayke B G Koek; Erik Buskens; Huib van Weelden; Paul H A Steegmans; Carla A F M Bruijnzeel-Koomen; Vigfús Sigurdsson
Journal:  BMJ       Date:  2009-05-07

Review 8.  Improving access to home phototherapy for patients with psoriasis: current challenges and future prospects.

Authors:  Sylvie M Franken; Carlijn L Vierstra; Thomas Rustemeyer
Journal:  Psoriasis (Auckl)       Date:  2016-05-18

9.  Home-based devices in dermatology: a systematic review of safety and efficacy.

Authors:  Marc Cohen; Evan Austin; Natasha Masub; Alana Kurtti; Christopher George; Jared Jagdeo
Journal:  Arch Dermatol Res       Date:  2021-05-03       Impact factor: 3.017

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.